Looking to Partner with the World CNS Series?
Following a year of significant pharma acquisitions, approvals of transformative first-in-class drugs, and a surge in financial backing to bolster innovation across new targets and preclinical pipelines, 2026 is set to continue this momentum, with more companies prioritising neuroscience drug development than ever before.
If you offer relevant capabilities in this space and would like to align your brand with the CNS community, contact us to promote your expertise through a bespoke commercial partnership package.
Having trouble downloading the brochure? Let us know and we’ll email it to you instead.
Download Your Copy of the Sponsorship Prospectus
Explore the Brand-New Agenda
Gain direct insight into how leading pharma and biotech teams are advancing COPD pipelines, with case studies and discussions focused on biomarker-led trials, emerging biologics, and strategies to overcome translational and regulatory barriers.
Partner With Us
Position your organisation alongside leading solution providers and engage directly with pharma and biotech teams actively advancing COPD pipelines, looking for partners to accelerate development.
Join a Highly Curated Respiratory Community
Build meaningful connections with the people shaping next-generation COPD